Tuesday, 8 September 2026

FDA clears new drug for rare skin condition
Drug Doses

FDA clears new drug for rare skin condition

The FDA approved Lisraya (brepocitinib) for dermatomyositis, a rare skin condition causing inflammation and muscle weakness, offering targeted treatment.

By Ember Pennington  •  August 28, 2026
Read More